Literature DB >> 21703401

Migration of fibrocytes in fibrogenic liver injury.

David Scholten1, Donna Reichart, Yong Han Paik, Jens Lindert, Jahar Bhattacharya, Christopher K Glass, David A Brenner, Tatiana Kisseleva.   

Abstract

CD45(+) and collagen I-positive (Col(+)) fibrocytes are implicated in fibrogenesis in skin, lungs, and kidneys. Fibrocyte migration in response to liver injury was investigated using bone marrow (BM) from chimeric mice expressing luciferase (Col-Luc→wt) or green fluorescent protein (Col-GFP→wt) under control of the α1(I) collagen promoter and enhancer, respectively. Monitored by luciferase expression, recruitment of fibrocytes was detected in CCl(4)-damaged liver and in spleen. Migration of CD45(+)Col(+) fibrocytes was regulated by chemokine receptors CCR2 and CCR1, as demonstrated, respectively, by 50% and 25% inhibition of fibrocyte migration in Col-Luc(CCR2-/-)→wt and Col-Luc(CCR1-/-)→wt mice. In addition to CCR2 and CCR1, egress of BM CD45(+)Col(+) cells was regulated by transforming growth factor-β1 (TGF-β1) and liposaccharide in vitro and in vivo, which suggests that release of TGF-β1 and increased intestinal permeability have important roles in fibrocyte trafficking. In the injured liver, fibrocytes gave rise to (myo)fibroblasts. In addition, a BM population of CD45(+)Col(+) cells capable of differentiation into fibrocytes in culture was identified. Egress of CD45(+)Col(+) cells from BM was detected in the absence of injury or stress in aged mice but not in young mice. Development of liver fibrosis was also increased in aged mice and correlated with high numbers of liver fibrocytes. In conclusion, in response to liver injury, fibrocytes migrate from BM to the liver. Their migration is regulated by CCR2 and CCR1 but is compromised with age.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703401      PMCID: PMC3123781          DOI: 10.1016/j.ajpath.2011.03.049

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

2.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

Authors:  Bethany B Moore; Jill E Kolodsick; Victor J Thannickal; Kenneth Cooke; Thomas A Moore; Cory Hogaboam; Carol A Wilke; Galen B Toews
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

Authors:  Tatiana Kisseleva; Hiroshi Uchinami; Nikki Feirt; Oscar Quintana-Bustamante; Jose Carlos Segovia; Robert F Schwabe; David A Brenner
Journal:  J Hepatol       Date:  2006-06-09       Impact factor: 25.083

Review 4.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

6.  Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.

Authors:  Norihiko Sakai; Takashi Wada; Hitoshi Yokoyama; Martin Lipp; Satoshi Ueha; Kouji Matsushima; Shuichi Kaneko
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

7.  The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.

Authors:  Bethany B Moore; Lynne Murray; Anuk Das; Carol A Wilke; Amy B Herrygers; Galen B Toews
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

8.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

Review 10.  The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses.

Authors:  Alberto Bellini; Sabrina Mattoli
Journal:  Lab Invest       Date:  2007-07-02       Impact factor: 5.662

View more
  54 in total

1.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

2.  Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis.

Authors:  Pedro H D M Prazeres; Anaelise O M Turquetti; Patrick O Azevedo; Rodrigo S N Barreto; Maria A Miglino; Akiva Mintz; Osvaldo Delbono; Alexander Birbrair
Journal:  Int J Biochem Cell Biol       Date:  2018-04-05       Impact factor: 5.085

Review 3.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

4.  Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro.

Authors:  Amanda B Muir; Diana M Lim; Alain J Benitez; Prasanna Modayur Chandramouleeswaran; Anna J Lee; Eduardo D Ruchelli; Jonathan M Spergel; Mei-Lun Wang
Journal:  Exp Cell Res       Date:  2012-12-10       Impact factor: 3.905

5.  Role of Schwann cells in cutaneous wound healing.

Authors:  Walison N Silva; Caroline Leonel; Pedro H D M Prazeres; Isadora F G Sena; Daniel A P Guerra; Debora Heller; Ivana M A Diniz; Vitor Fortuna; Akiva Mintz; Alexander Birbrair
Journal:  Wound Repair Regen       Date:  2018-10-29       Impact factor: 3.617

Review 6.  Molecular and cellular mechanisms of liver fibrosis and its regression.

Authors:  Tatiana Kisseleva; David Brenner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-30       Impact factor: 46.802

7.  TGFβ and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo.

Authors:  Vivek Singh; Ritika Jaini; André A M Torricelli; Marcony R Santhiago; Nirbhai Singh; Bala K Ambati; Steven E Wilson
Journal:  Exp Eye Res       Date:  2014-02-26       Impact factor: 3.467

Review 8.  Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.

Authors:  Gabriela Campanholle; Giovanni Ligresti; Sina A Gharib; Jeremy S Duffield
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

Review 9.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

Review 10.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.